|
|
|||||||||||||
|
|
||||||||||||||
These articles have received the most "hits" in British Journal of Ophthalmology during June 2008.
|
||||||
| 6. | N Shimada, K Ohno-Matsui, T Yoshida, Y Sugamoto, T Tokoro, M Mochizuki | ||
| Progression from macular retinoschisis to retinal detachment in highly myopic eyes is associated with outer lamellar hole formation | |||
|---|---|---|---|
|
Br. J. Ophthalmol. 2008; 92: 762-764.
(In "Original articles - Clinical science") |
|||
| 7. | A E Fung, P J Rosenfeld, E Reichel | ||
| The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide | |||
|
Br. J. Ophthalmol. 2006; 90: 1344-1349.
(In "World view") |
|||
| 8. | S Flores Moreno, J Bautista Paloma | ||
| Therapeutic anti-VEGF in age-related macular degeneration: Ranibizumab and Bevacizumab controversy | |||
|
Br. J. Ophthalmol. 2008; 92: 866-867.
(In "PostScript") |
|||
| 9. | M Yamada, J Yoshida, S Hatou, T Yoshida, Y Minagawa | ||
| Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones | |||
|
Br. J. Ophthalmol. 2008; 92: 848-851.
(In "Original articles - Laboratory science") |
|||
| 10. | G Weigert, S Michels, S Sacu, A Varga, F Prager, W Geitzenauer, U Schmidt-Erfurth | ||
| Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study | |||
|
Br. J. Ophthalmol. 2008; 92: 356-360.
(In "Original articles - Clinical science") |
|||
| [Previous 5 Articles] | |||
= from the current issue
Last Updated: 07/03/2008 19:42:28
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | REGISTER |